Divis Laboratories

Sun Pharma sees Golden Cross; other pharma stocks with similar pattern

Technically, the term 'Golden Cross' has bullish implications with short-term support seen moving higher. Apart from Sun Pharma, Aurobindo Pharma and Divi's Labs too witnessed this formation recently.

Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's

Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators; check more details

Divi's Labs falls 4% after Q1 miss, analysts trim estimates; check details

Divi's Laboratories reported a 14 per cent year-on-year jump in revenue at ₹2,410 crore in Q1FY26, compared to ₹2,118 crore in the year-ago period

Divis Labs bucks weak pharma shares trend; hits new high on strong Q1 hopes

In the past six months, the Divis Labs stock has outperformed the market by surging 18 per cent, as against 1.4 per cent fall in the BSE Healthcare index and 7 per cent rise in the BSE Sensex.

Divi's Labs share up 4%, hits record high on inking supply deal; details

Divi's Laboratories share price rose after the company announced that it has inked a long-term manufacturing and supply agreement with a global pharmaceutical company.

Strong growth seen for Divi's Laboratories, but upside capped by valuations

Divi's posted a 12 per cent growth in revenues over the year-ago quarter. Although revenue growth has moderated after four consecutive quarters of top line growth in the 18-25 per cent range

Divi's Labs clocks all-time high on posting Q4 results: Check details

Divi's Labs share price jumped 5 per cent after posting healthy Q4 results and announcing 1,500 per cent dividend

Nifty Pharma drops 2% after Trump reveals plans to lower US drug cost

The US President has predicted that pharmaceutical prices could drop 30 per cent to 80 per cent in America

Divi's Labs jumps 4% after signing supply agreement with global pharma firm

Divi's Labs stock was quoting at ₹5,855.50, up 3.81 per cent from Thursday, April 17 close of ₹5,640

Biocon, Cipla: Nifty Pharma down 6% as US eyes possible tariffs on sector

Adding to the worries of investors, US is looking for possible tariffs on the pharmaceutical goods

Nifty Pharma jumps 5% as US exempts reciprocal tariff on pharma goods

All 20 Nifty Pharma constituents settled in the green. Among others, Ipca Laboratories was up 4.59 per cent, Lupin was up 4.19 per cent, Cipla was up 3.28 per cent, Sun Pharma was up 3.41 per cent

Suven Pharma, Divis, Syngene: Why Macquarie is betting big on Indian pharma

Pharma stocks list: Divis Labs share price rallied 1.9% intraday, Suven Pharma share price surged 4.6%, Blue Jet Healthcare share price added 4.9%, and Syngene International share price rose 1.5%

Divi's Labs Q3 results: PAT rises 64.5% to Rs 589 cr on strong API demand

Its revenue from operations climbed 25 per cent to Rs 2,319 crore during the quarter, roughly in line with analysts' estimate of Rs 2,343 crore

Divi's Laboratories shares slip 6% in trade; what's worrying investors?

The filing further said that the financials of the company won't be impacted and the penalty will be paid within the prescribed timeline

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR

The PCR (Put Call Ratio) of these 3 stocks is above 1, implying presence of higher open positions in Puts as against Calls, shows the NSE options data.

Divi's Lab, AEL, M&M among top movers & shakers in FY25; trading guide here

Among existing gainers, Divi's Lab and Shriram Finance seem poised for further gains, whereas losers IndusInd Bank and Nestle too look promising on technical charts; check key levels.

Divi's Labs shares jump 5% as US court stays FDA approval for Entresto drug

Shares of Divi's Laboratories surged up to 5 per cent at Rs 4960 per share on the BSE in Wednesday's intraday deals

BSE Healthcare hits new high; rallies 10% in 1 month on strong outlook

Solara Active Pharma Sciences, Indoco Remedies, Dishman Carbogen Amcis, Krishna Institute of Medical Sciences, Divi's Lab, Strides Pharma, Narayana Hrudayalaya and Vijaya Diagnostic were up 5 per cent

Stock Market Highlights, Aug 5: Sensex tanks 2,223 points; Nifty ends near 24,050 amid global rout

Stock Market Live updates on August 5: Indian bourses are staring at a bear attack on Monday after heavy sell-off in global peers. The GIFT Nifty futures also indicated a gap-down start,

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts

Analysts say pharmaceutical company's stock fully priced in